Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer

Exclusion Criteria

• •1. Has a life expectancy of \<3 months.
• •2. Is pregnant, as confirmed through a blood test prior to any study procedure, planning on becoming pregnant during the study, or is lactating.
• •3. Will be receiving intraperitoneal chemotherapy.
• •4. Has undergone prior treatment with abdominal and/or pelvic radiotherapy.
• •5. Has significant active concurrent medical illnesses including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
• •6. Presence of central nervous system or cerebral metastases.
• •7. Recurrent ovarian cancer.
• •8. Complete resection with no residual tumor after primary tumor debulking surgery.
• •9. Suboptimal resection with \>1 cm residual tumor after primary or interval tumor debulking surgery.
• •10. Is simultaneously enrolled in another investigational study.
• •11. Has a history of cancer within 5 years other than in-situ uterine cervix cancer or non-melanoma skin cancer.
• •12. Has a known hypersensitivity to carboplatin or paclitaxel.
• •13. Is concurrently using other antineoplastic agents.